The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
Open accessAbstract
Porous silicon (PSi) particles have been studied for the effects they elicit in Caco-2 and RAW 264.7 macrophage cells in terms of toxicity, oxidative stress, and inflammatory response. The most suitable particles were then functionalized with a novel (18)F label to assess their biodistribution after enteral and parenteral administration in a rat model. The results show that thermally hydrocarbonized porous silicon (THCPSi) nanoparticles did not induce any significant toxicity, oxidative stress, or inflammatory response in Caco-2 and RAW 264.7 macrophage cells. Fluorescently labeled nanoparticles were associated with the cells surface but were not extensively internalized. Biodistribution studies in rats using novel (18)F-labeled THCPSi nanoparticles demonstrated that the particles passed intact through the gastrointestinal tract after oral administration and were also not absorbed from a subcutaneous deposit. After intravenous administration, the particles were found mainly in the liver and spleen, indicating rapid removal from the circulation. Overall, these silicon-based nanosystems exhibit excellent in vivo stability, low cytotoxicity, and nonimmunogenic profiles, ideal for oral drug delivery purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells
AshaRani, P. V., Low Kah Mun, G., Hande, M. P., & Valiyaveettil, S. (2009) · ACS Nano · doi:10.1021/nn800596w · Cited by 3,692
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
Park, J.-H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Nature Materials · doi:10.1038/nmat2398 · Cited by 1,897
A Porous Silicon-Based Optical Interferometric Biosensor
Lin, V. S.-Y., Motesharei, K., Dancil, K.-P. S., Sailor, M. J., & Ghadiri, M. R. (1997) · Science · doi:10.1126/science.278.5339.840 · Cited by 1,299
Porous silicon in drug delivery devices and materials☆
ANGLIN, E., CHENG, L., FREEMAN, W., & SAILOR, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.017 · Cited by 889
A controlled-release microchip
Santini, J. T., Cima, M. J., & Langer, R. (1999) · Nature · doi:10.1038/16898 · Cited by 868
Biocompatible Luminescent Silicon Quantum Dots for Imaging of Cancer Cells
Erogbogbo, F., Yong, K.-T., Roy, I., Xu, G., Prasad, P. N., & Swihart, M. T. (2008) · ACS Nano · doi:10.1021/nn700319z · Cited by 684
Bioactive silicon structure fabrication through nanoetching techniques
Canham, L. (1995) · Advanced Materials · doi:10.1002/adma.19950071215 · Cited by 625
Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs
Salonen, J., Laitinen, L., Kaukonen, A. M., Tuura, J., Björkqvist, M., Heikkilä, T., Vähä-Heikkilä, K., Hirvonen, J., & Lehto, V.-P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.017 · Cited by 541
Self-citationChemistry with [18F]Fluoride Ion
Cai, L., Lu, S., & Pike, V. W. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800114 · Cited by 469
Mesoporous Silicon in Drug Delivery Applications
Salonen, J., Kaukonen, A. M., Hirvonen, J., & Lehto, V.-P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20999 · Cited by 464
Self-citationThe biocompatibility of porous silicon in tissues of the eye
Low, S. P., Voelcker, N. H., Canham, L. T., & Williams, K. A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.008 · Cited by 329
Foraker, A. B., Walczak, R. J., Cohen, M. H., Boiarski, T. A., Grove, C. F., & Swaan, P. W. (2003) · Pharmaceutical Research · doi:10.1023/a:1022211127890 · Cited by 206
Santos, H. A., Riikonen, J., Salonen, J., Mäkilä, E., Heikkilä, T., Laaksonen, T., Peltonen, L., Lehto, V.-P., & Hirvonen, J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.12.043 · Cited by 178
Self-citationStabilization of porous silicon surface by thermal decomposition of acetylene
Salonen, J., Björkqvist, M., Laine, E., & Niinistö, L. (2003) · Applied Surface Science · doi:10.1016/j.apsusc.2003.10.028 · Cited by 155
Self-citationOxidized Mesoporous Silicon Microparticles for Improved Oral Delivery of Poorly Soluble Drugs
Wang, F., He, H. Z., Barnes, T. J., Barnett, C., & Prestidge, C. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900221e · Cited by 150
Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
Laaksonen, T., Santos, H. A., Vihola, H., Salonen, J., Riikonen, J., Heikkilä, T., Peltonen, L., Kumar, N., Murzin, D. Y., Lehto, V., et al. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700326b · Cited by 139
Self-citationIn vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
Kilpeläinen, M., Riikonen, J., Vlasova, M. A., Huotari, A., Lehto, V., Salonen, J., Herzig, K., & Järvinen, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.017 · Cited by 137
Self-citationCheng, L., Anglin, E. J., Cunin, F., Kim, D., Sailor, M. J., FALKENSTEIN, I. A., Tammewar, A. M., & Freeman, W. R. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.133587 · Cited by 131
Schou, M., Halldin, C., Sóvágó, J., Pike, V. W., Hall, H., Gulyás, B. Z., Mozley, P. D., Dobson, D. R., Shchukin, E., Innis, R. B., et al. (2004) · Synapse · doi:10.1002/syn.20031 · Cited by 129
Choi, J. H., Zhang, Q., Reipa, V., Wang, N. S., Stratmeyer, M. E., Hitchins, V. M., & Goering, P. L. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1382 · Cited by 114
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles
Limnell, T., Riikonen, J., Salonen, J., Kaukonen, A. M., LAITINEN, L., Hirvonen, J. J., & Lehto, V.-P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.010 · Cited by 105
Self-citationCytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
Heikkilä, T., Santos, H. A., Kumar, N., Murzin, D. Y., Salonen, J., Laaksonen, T., Peltonen, L., Hirvonen, J. J., & Lehto, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.12.006 · Cited by 105
Self-citationBølling, A. K., Totlandsdal, A. I., Låg, M., Refsnes, M., & Schwarze, P. E. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.014 · Cited by 95
Kaukonen, A. M., Laitinen, L., Salonen, J., Tuura, J., Heikkilä, T., Limnell, T., Hirvonen, J. J., & Lehto, V. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.021 · Cited by 94
Self-citationControlled release technologies for drug delivery
Brayden, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02874-5 · Cited by 89
Design of silicon-based misonidazole analogues and 18F-radiolabelling
Bohn, P., Deyine, A., Azzouz, R., Bailly, L., Fiol‐Petit, C., Bischoff, L., Fruit, C., Marsais, F., & Véra, P. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.06.004 · Cited by 27
Cited by
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Croissant, J. G., Fatieiev, Y., & Khashab, N. M. (2017) · Advanced Materials · doi:10.1002/adma.201604634 · Cited by 782
A general mechanism for intracellular toxicity of metal-containing nanoparticles
Sabella, S., Carney, R. P., Brunetti, V., Malvindi, M. A., Al-Juffali, N., Vecchio, G., Janes, S. M., Bakr, O. M., Cingolani, R., Stellacci, F., et al. (2014) · Nanoscale · doi:10.1039/c4nr01234h · Cited by 467
Quantum Dot Cytotoxicity and Ways To Reduce It
Winnik, F. M., & Maysinger, D. (2013) · Accounts of Chemical Research · doi:10.1021/ar3000585 · Cited by 330
The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
Figueiredo, P., Bauleth-Ramos, T., Hirvonen, J., Sarmento, B., & Santos, H. A. (2018) · Handbook of Nanomaterials for Cancer Theranostics · doi:10.1016/b978-0-12-813339-2.00001-3 · Cited by 287
Self-citation
Metadata
- Authors
- Bimbo, L. M., Sarparanta, M., Santos, H. A., Airaksinen, A. J., Mäkilä, E., Laaksonen, T., Peltonen, L., Lehto, V.-P., Hirvonen, J., & Salonen, J.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-28
- Volume
- 4
- Issue
- 6
- Pages
- 3023-3032
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2046420363
- Cited by
- 335
- References
- 31
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.